Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026)
Protalix BioTherapeutics' quarterly Deferred Taxes came in at $71000.0 in Q1 2026, up 162.83% year-on-year from $27013.5 in Q1 2025, and down 56.44% quarter-over-quarter from $163000.0 in Q4 2025.
Protalix BioTherapeutics has reported Deferred Taxes for 4 years, with the latest figure at $71000.0 in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 162.83% year-over-year to $71000.0; the trailing twelve-month figure through Mar 2026 stood at $524000.0 (up 100.77% YoY), and the FY2025 full-year result was $340000.0, up 44.07% from the prior year.
- Deferred Taxes for Q1 2026 stood at $71000.0, down from $163000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $443000.0 in Q3 2024, with the low at -$3.1 million in Q2 2023.
- Average Deferred Taxes over 4 years is -$244500.0, with a median of $48500.0 recorded in 2023.
- Year-over-year, Deferred Taxes jumped 1065.79% in 2024 and slumped 86.68% in 2025.
- Tracing PLX's Deferred Taxes over 4 years: stood at $38000.0 in 2023, then jumped by 1065.79% to $443000.0 in 2024, then slumped by 63.21% to $163000.0 in 2025, then tumbled by 56.44% to $71000.0 in 2026.
- The last three Deferred Taxes figures came in at $71000.0 (Q1 2026), $163000.0 (Q4 2025), and $59000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 71,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 163,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 231,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Sep 30, 2024 | 443,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Jun 30, 2023 | -3.13 Mn |